The use of urinary markers to improve adherence to the treatment of osteopoerosis
| ISRCTN | ISRCTN54722759 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN54722759 |
| Secondary identifying numbers | N0231117494 |
- Submission date
- 12/09/2003
- Registration date
- 12/09/2003
- Last edited
- 28/09/2011
- Recruitment status
- Stopped
- Overall study status
- Stopped
- Condition category
- Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Muhammad Javaid
Scientific
Scientific
MRC EEU
Southampton General Hospital
Tremona Road
Southampton
SO16 6YD
United Kingdom
| Phone | +44 023 8077 7624 |
|---|---|
| mkj@mrc.soton.ac.uk |
Study information
| Study design | Placebo controlled prospective randomized clinical trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Not specified |
| Study type | Not Specified |
| Scientific title | |
| Study objectives | Do measurements of bone markers improve patients compliance to therapy? |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Musculoskeletal Diseases: Osteoporosis |
| Intervention | Urinary markers vs placebo Added July 2008: the trial was stopped due to lack of participants. |
| Intervention type | Other |
| Primary outcome measure | Compliance to medication at 1 year, change in bone mineral density at 1 year. |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 01/11/2002 |
| Completion date | 31/10/2005 |
| Reason abandoned (if study stopped) | Lack of participants |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target number of participants | Not provided at time of registration |
| Key inclusion criteria | Patients starting drug therapy for treatment of osteoporosis. |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/11/2002 |
| Date of final enrolment | 31/10/2005 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
MRC EEU
Southampton
SO16 6YD
United Kingdom
SO16 6YD
United Kingdom
Sponsor information
Department of Health (UK)
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
| Website | http://www.doh.gov.uk |
|---|
Funders
Funder type
Government
Southampton University Hospitals NHS Trust (UK)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
